Daxor Ownership | Who Owns Daxor?
Daxor Ownership Summary
Daxor is owned by 1.05% institutional investors, 56.64% insiders, and 42.31% retail investors. Vanguard group is the largest institutional shareholder, holding 0.98% of DXR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.97% of its assets in Daxor shares.
DXR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Daxor | 1.05% | 56.64% | 42.31% |
| Sector | Healthcare Stocks | 42.64% | 10.86% | 46.50% |
| Industry | Medical Instruments & Supplies Stocks | 40.77% | 13.85% | 45.38% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 49.03K | 0.98% | $723.16K |
| Renaissance | 28.22K | 0.57% | $416.26K |
| Keyes, stange & wooten wealth management | 15.91K | 0.33% | $155.80K |
| Nano cap new millennium growth fund l p | 12.50K | 0.25% | $184.38M |
| Morgan stanley | 3.24K | 0.06% | $47.75K |
| Sbi securities | 3.13K | 0.06% | $46.14K |
| Ubs group | 90.00 | 0.00% | $1.33K |
| Jpmorgan chase | 5.00 | 0.00% | $74.00 |
| Princeton global asset management | - | - | - |
| Jones financial companies lllp | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Nano cap new millennium growth fund l p | 12.50K | 0.16% | $184.38M |
| Keyes, stange & wooten wealth management | 15.91K | 0.08% | $155.80K |
| Sbi securities | 3.13K | 0.00% | $46.14K |
| Renaissance | 28.22K | 0.00% | $416.26K |
| Jpmorgan chase | 5.00 | - | $74.00 |
| Ubs group | 90.00 | - | $1.33K |
| Advisor group | - | - | - |
| Vanguard group | 49.03K | - | $723.16K |
| Morgan stanley | 3.24K | - | $47.75K |
| Jones financial companies lllp | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Nano cap new millennium growth fund l p | 12.50K | 0.16% | 12.50K |
| Ubs group | 90.00 | - | 90.00 |
| Jpmorgan chase | 5.00 | - | 1.00 |
| Keyes, stange & wooten wealth management | 15.91K | 0.08% | - |
| Vanguard group | 49.03K | - | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Advisor group | - | - | -8.75K |
| Renaissance | 28.22K | 0.00% | -700.00 |
| Princeton global asset management | - | - | -500.00 |
| Morgan stanley | 3.24K | - | -300.00 |
| Jones financial companies lllp | - | - | -100.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Nano cap new millennium growth fund l p | 12.50K | 0.16% | 12.50K | $184.38M |
| Ubs group | 90.00 | - | 90.00 | $1.33K |
Sold Out
| Holder | Change |
|---|---|
| Jones financial companies lllp | -100.00 |
| Princeton global asset management | -500.00 |
| Advisor group | -8.75K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 3 | -57.14% | 52,160 | -51.88% | 1 | 20.88% | - | -100.00% | - | -100.00% |
| Jun 30, 2025 | 7 | - | 108,400 | 12.21% | 2 | 56.25% | 2 | -33.33% | 1 | -66.67% |
| Mar 31, 2025 | 7 | -22.22% | 96,608 | -7.80% | 1 | 42.39% | 3 | -25.00% | 3 | - |
| Dec 31, 2024 | 9 | - | 104,781 | 20.02% | 2 | 66.68% | 4 | - | - | -100.00% |
| Sep 30, 2024 | 9 | 50.00% | 87,303 | 9.89% | 1 | 61.29% | 4 | 100.00% | 2 | 100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 47.98K | 0.97% | -1.05K |
| Bridgeway Ultra-Small Company Market | 6.30K | 0.13% | -3.10K |
| NT Quality SCC US Fund - L | 626.00 | 0.01% | -50.00 |
| NT Quality Small Cap Core | 626.00 | 0.01% | -50.00 |
| Gabelli Global Mini Mites I | 400.00 | 0.01% | - |
| Northern Small Cap Core I | 37.00 | 0.00% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 09, 2025 | Michel Robert J | Chief Financial Officer | Buy | - |
| Dec 09, 2025 | Feldschuh Jonathan Adam | Chief Scientific Officer | Buy | - |
| Nov 12, 2025 | Jefferies John | Chief Medical Officer | Buy | - |
| Apr 04, 2025 | Feldschuh Michael Richard | Chief Executive Officer | Buy | $16.28K |
| Mar 26, 2024 | Feldschuh Michael Richard | Chief Executive Office | Buy | $8.13K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | 3 | - |
| 2025 Q3 | - | - |
| 2025 Q2 | 1 | - |
| 2025 Q1 | 2 | - |
| 2024 Q4 | 2 | - |
DXR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools